US 6998117
Cancer treatment with retroviral vectors comprising wild-type p53
expired A61KA61K38/00A61K38/1709
Quick answer
US patent 6998117 (Cancer treatment with retroviral vectors comprising wild-type p53) held by The Board of Regents of the University of Texas System expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K38/00, A61K38/1709, A61K48/00